Rocket Pharmaceuticals Inc (NASDAQ:RCKT) price on current trading day, rose 12.73% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $5.40.
A look at the stock’s price movement, the close in the last trading session was $4.79, moving within a range at $4.55 and $5.75. The beta value (5-Year monthly) was 0.996. Turning to its 52-week performance, $26.98 and $4.60 were the 52-week high and 52-week low respectively. Overall, RCKT moved -34.23% over the past month.
Rocket Pharmaceuticals Inc’s market cap currently stands at around $575.80 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-26.
Turning to the stock’s technical picture we see that short term indicators suggest on average that RCKT is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
8 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 7 recommend RCKT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
RCKT’s current price about -25.29% and -38.85% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 31.53, while 7-day volatility ratio is 14.31% and 9.01% in the 30-day chart. Further, Rocket Pharmaceuticals Inc (RCKT) has a beta value of 1.18, and an average true range (ATR) of 0.66. Analysts have given the company’s stock an average 52-week price target of $35.5, forecast between a low of $32 and high of $39. Looking at the price targets, the low is -492.59% off current price level while to achieve the yearly target high, price needs to move -622.22%. Nonetheless, investors will most likely welcome a -557.41% jump to $35.5 which is the analysts’ median price.
If we refocus on Rocket Pharmaceuticals Inc (NASDAQ:RCKT), historical trading data shows that trading volumes averaged 4.7 over the past 10 days and 1.94 million over the past 3 months. The company’s latest data on shares outstanding shows there are 106.45 million shares.
The 7.18% of Rocket Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 101.06% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 11.05 million on 2025-03-14, giving us a short ratio of 8.06. The data shows that as of 2025-03-14 short interest in Rocket Pharmaceuticals Inc (RCKT) stood at 1887.9999000000003 of shares outstanding, with shares short falling to 11.24 million registered in 2025-02-14. Current price change has pushed the stock -57.04% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RCKT stock continues to rise going into the next quarter.
